Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-06-01 02:41 | 2016-05-26 | CEQP | N/A | First Reserve GP XI, Inc. | Director, 10% owner | Other | BUY | $21.45 | 136,705 | $2,932,842 | 7,022,313 | +2.0% |
| 2016-05-31 22:23 | 2016-05-26 | NSPH | N/A | MMCAP International Inc. SPC | 10% owner | Other | BUY | $1.70 | 2,262,705 | $3,843,883 | 7,669,290 | +41.9% |
| 2016-05-31 23:12 | 2016-05-26 | P | N/A | CROSSLINK CAPITAL INC | Other | Other | BUY | $11.33 | 250,000 | $2,831,850 | 6,661,294 | +3.9% |
| 2016-06-01 01:14 | 2016-05-31 | WDC | WESTERN DIGITAL CORP | MILLIGAN STEPHEN D | Director, Officer - Chief Executive Officer | Computer Storage Devices | BUY | $45.53 | 22,500 | $1,024,425 | 22,567 | +33,582.1% |
| 2016-05-31 23:29 | 2016-05-24 | HT | N/A | LEVEN MICHAEL A | Director | Other | BUY | $25.00 | 40,000 | $1,000,000 | 40,000 | +100.0% |
| 2016-05-28 01:44 | 2016-05-25 | CETV | N/A | TCS CAPITAL MANAGEMENT LLC | 10% owner | Other | BUY | $2.44 | 479,674 | $1,171,748 | 16,749,507 | +2.9% |
| 2016-05-27 23:19 | 2016-05-25 | P | N/A | CROSSLINK CAPITAL INC | Other | Other | BUY | $10.97 | 250,000 | $2,741,775 | 6,411,294 | +4.1% |
| 2016-05-27 04:49 | 2016-05-24 | BH | N/A | BIGLARI, SARDAR | Director, 10% owner | Other | BUY | $378.85 | 3,126 | $1,184,285 | 643,438 | +0.5% |
| 2016-05-26 23:31 | 2016-05-25 | FDC | N/A | PLUMERI JOSEPH J | Director | Other | BUY | $12.30 | 250,000 | $3,074,900 | 478,664 | +109.3% |
| 2016-05-26 21:50 | 2016-05-26 | ALDX | Aldeyra Therapeutics Inc. | PERCEPTIVE ADVISORS LLC | 10% owner | Pharmaceutical Preparations | BUY | $5.00 | 700,000 | $3,500,000 | 1,940,458 | +56.4% |
| 2016-05-27 04:13 | 2016-05-24 | CEQP | N/A | First Reserve GP XI, Inc. | Director, 10% owner | Other | BUY | $20.69 | 289,894 | $5,996,544 | 6,885,608 | +4.4% |
| 2016-05-27 03:02 | 2016-05-24 | PSX | Phillips 66 | BERKSHIRE HATHAWAY INC | 10% owner | Petroleum Refining | BUY | $79.76 | 642,273 | $51,225,254 | 77,017,648 | +0.8% |
| 2016-05-26 01:45 | 2016-05-20 | ADAP | Adaptimmune Therapeutics PLC | Thompson Peter A. | Director | Biological Products, (No Diagnostic Substances) | BUY | $10.42 | 1,712,400 | $17,849,544 | 29,753,404 | +6.1% |
| 2016-05-26 00:44 | 2016-05-23 | PZRX | N/A | GILLIS STEVEN | Director, 10% owner | Other | BUY | $5.00 | 1,000,000 | $5,000,000 | 2,854,222 | +53.9% |
| 2016-05-26 04:36 | 2016-05-25 | AAP | ADVANCE AUTO PARTS INC | Smith Jeffrey C | Director | Retail-Auto & Home Supply Stores | BUY | $152.73 | 150,000 | $22,909,500 | 524,195 | +40.1% |
| 2016-05-26 01:41 | 2016-05-20 | ADAP | Adaptimmune Therapeutics PLC | ORBIMED ADVISORS LLC | Director | Biological Products, (No Diagnostic Substances) | BUY | $10.42 | 1,712,400 | $17,849,544 | 29,753,404 | +6.1% |
| 2016-05-26 00:07 | 2016-05-23 | NATI | N/A | TRUCHARD JAMES J | Director, Officer, 10% owner - President | Other | BUY | $27.50 | 394,819 | $10,855,548 | 9,458,916 | +4.4% |
| 2016-05-24 23:09 | 2016-05-20 | GE | GENERAL ELECTRIC CO | IMMELT JEFFREY R | Director, Officer - Chairman and CEO | Electronic & Other Electrical Equipment (No Computer Equip) | BUY | $29.59 | 67,600 | $2,000,284 | 2,158,688 | +3.2% |
| 2016-05-25 00:05 | 2016-05-23 | PZRX | N/A | ATWOOD BRIAN G | Director, 10% owner | Other | BUY | $5.00 | 600,000 | $3,000,000 | 1,931,094 | +45.1% |
| 2016-05-25 01:14 | 2016-05-20 | TCFC | N/A | BASSWOOD CAPITAL MANAGEMENT, L.L.C. | Director, Other | Other | BUY | $21.40 | 51,457 | $1,101,000 | 2,259 | +100.0% |
| 2016-05-24 03:01 | 2016-05-19 | PSX | Phillips 66 | BERKSHIRE HATHAWAY INC | 10% owner | Petroleum Refining | BUY | $77.79 | 824,630 | $64,148,710 | 76,375,375 | +1.1% |
| 2016-05-20 23:30 | 2016-05-18 | SRG | Seritage Growth Properties | BERKOWITZ BRUCE R | 10% owner | Real Estate | BUY | $43.66 | 37,700 | $1,645,843 | 3,488,750 | +1.1% |
| 2016-05-21 00:55 | 2016-05-18 | CEQP | N/A | First Reserve GP XI, Inc. | Director, 10% owner | Other | BUY | $17.90 | 81,086 | $1,451,472 | 6,552,200 | +1.3% |
| 2016-05-21 04:54 | 2015-04-27 | ABTL | N/A | Tezanos Matias de | Director, Officer, 10% owner - Chief Strategy Officer | Other | BUY | $4.65 | 324,078 | $1,506,963 | 324,078 | +100.0% |
| 2016-05-19 13:47 | 2016-05-18 | IDI | Fluent, Inc. | Brauser Michael | Director, Officer - Executive Chairman | Services-Advertising | BUY | $5.25 | 419,530 | $2,202,533 | 1,373,646 | +44.0% |
| 2016-05-20 00:08 | 2016-05-18 | FDC | N/A | NUTTALL SCOTT C | Director | Other | BUY | $10.62 | 100,000 | $1,062,000 | 25,000 | +100.0% |
| 2016-05-19 23:24 | 2016-05-17 | LOXO | N/A | AISLING CAPITAL III LP | 10% owner | Other | BUY | $21.50 | 232,558 | $4,999,997 | 4,028,920 | +6.1% |
| 2016-05-19 15:38 | 2016-05-17 | PODD | INSULET CORP | SULLIVAN PATRICK J | Director, Officer - President & CEO | Surgical & Medical Instruments & Apparatus | BUY | $27.00 | 45,000 | $1,215,185 | 217,795 | +26.0% |
| 2016-05-18 16:53 | 2016-05-12 | EUSP | N/A | Samaras Elias | Director, Officer, 10% owner - Chief Executive Officer | Other | BUY | $0.58 | 6,086,957 | $3,500,000 | 9,523,312 | +177.1% |
| 2016-05-19 01:39 | 2016-05-16 | WNRL | N/A | Stevens Jeff A | Director, Officer - President and CEO | Other | BUY | $21.73 | 138,057 | $2,999,979 | 276,283 | +99.9% |
| 2016-05-19 01:46 | 2016-05-16 | WNRL | N/A | Foster Paul L | Director | Other | BUY | $21.73 | 276,115 | $5,999,979 | 530,563 | +108.5% |
| 2016-05-18 23:31 | 2016-05-17 | NYMT | Adamas Trust, Inc. | Donlon Kevin M. | Officer - President | Real Estate Investment Trusts | BUY | $5.66 | 200,000 | $1,132,880 | 206,000 | +3,333.3% |
| 2016-05-19 03:08 | 2016-05-16 | CEQP | N/A | First Reserve GP XI, Inc. | Director, 10% owner | Other | BUY | $18.29 | 186,960 | $3,420,209 | 6,471,114 | +3.0% |
| 2016-05-19 04:51 | 2016-05-16 | WLH | N/A | GMT CAPITAL CORP | 10% owner | Other | BUY | $14.30 | 436,100 | $6,236,230 | 4,562,917 | +10.6% |
| 2016-05-18 00:35 | 2016-05-13 | APPF | Appfolio Inc. | STAD MARC | 10% owner | Services-Prepackaged Software | BUY | $12.70 | 345,477 | $4,386,245 | 2,057,344 | +20.2% |
| 2016-05-17 20:04 | 2016-05-16 | NA | N/A | KUHLERS CHAD E | Officer - Chief Operating Officer | Other | BUY | $49,920.00 | 8,000 | $399,360,000 | 20,166 | +65.8% |
| 2016-05-17 19:46 | 2016-05-16 | NA | N/A | Lynch Duane F | Director | Other | BUY | $62,400.00 | 10,000 | $624,000,000 | 110,000 | +10.0% |
| 2016-05-17 20:18 | 2016-05-16 | NA | N/A | Sovereign David A | Director | Other | BUY | $43,680.00 | 7,000 | $305,760,000 | 107,000 | +7.0% |
| 2016-05-16 23:17 | 2016-05-06 | AYTU | AYTU BIOPHARMA, INC | DOCKERY CARL | Director | Pharmaceutical Preparations | BUY | $0.40 | 5,000,000 | $2,000,000 | 5,047,591 | +10,506.2% |
| 2016-05-16 19:07 | 2016-05-12 | WNR | N/A | Foster Paul L | Director, Officer, 10% owner - Chairman of BOD, Exec. Chair | Other | BUY | $21.60 | 500,000 | $10,800,100 | 3,430,619 | +17.1% |
| 2016-05-17 00:56 | 2016-05-12 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS LP | 10% owner | Ophthalmic Goods | BUY | $5.49 | 336,210 | $1,847,440 | 10,753,880 | +3.2% |
| 2016-05-17 00:22 | 2016-05-12 | HPP | Hudson Pacific Properties, Inc. | GLASER JONATHAN M | Director | Real Estate | BUY | $28.74 | 35,500 | $1,020,164 | 156,498 | +29.3% |
| 2016-05-16 23:04 | 2016-05-12 | STC | STEWART INFORMATION SERVICES CORP | CHADWICK JAMES M | Director | Title Insurance | BUY | $36.40 | 55,000 | $2,002,050 | 85,000 | +183.3% |
| 2016-05-17 00:21 | 2016-05-11 | BID | N/A | GOSS MICHAEL F | Officer - EVP, Chief Financial Officer | Other | BUY | $27.72 | 50,000 | $1,386,175 | 50,000 | +100.0% |
| 2016-05-17 01:10 | 2016-05-13 | AAL | American Airlines Group Inc. | BENJAMIN JEFFREY D | Director | Air Transportation, Scheduled | BUY | $31.79 | 35,000 | $1,112,517 | 35,000 | +100.0% |
| 2016-05-16 13:20 | 2016-05-13 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director, Officer, 10% owner - Chief Executive Officer | Pharmaceutical Preparations | BUY | $23.92 | 41,830 | $1,000,574 | 6,649,997 | +0.6% |
| 2016-05-13 16:14 | 2016-05-11 | PRAA | PRA GROUP INC | ROBERTS DAVID N | Director | Short-Term Business Credit Institutions | BUY | $25.25 | 40,000 | $1,009,800 | 30,000 | +100.0% |
| 2016-05-14 01:27 | 2016-05-11 | CWEI | N/A | ARES MANAGEMENT LLC | Director, 10% owner | Other | BUY | $17.95 | 515,405 | $9,251,056 | 879,023 | +141.7% |
| 2016-05-14 00:52 | 2016-05-12 | REED | REED'S, INC. | COHANE NEAL | Officer - SVP SALES | Bottled & Canned Soft Drinks & Carbonated Waters | BUY | $39,000.00 | 10,000 | $390,000,000 | 158,573 | +6.7% |
| 2016-05-14 00:50 | 2016-05-12 | REED | REED'S, INC. | Miles Daniel V. | Officer - CFO | Bottled & Canned Soft Drinks & Carbonated Waters | BUY | $39,000.00 | 10,000 | $390,000,000 | 10,000 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.